ATM and B-cell chronic lymphocytic leukemia: The FA-ATM synthetic lethal relationship is particularly interesting since ATM deficiency has been reported in a subset of patients with hematological malignancies, including mantle cell lymphoma, chronic lymphocytic leukemia, and acute lymphoblastic leukemia [53, 54], making these potential targets for treatment with FA pathway inhibitors (see Table 2).